WGS — GeneDx Holdings Corp.
—
Nasdaq ·
Health Care ·
Health Care Providers & Services ·
CIK 1818331 ·
Last close
$49.44
Market Cap
$1.47B
52W High
$95.38
52W Low
$32.21
ADV30
1,628,055
Next earnings
2026-07-28
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Mar 2026 | 102,254,000 | 68,211,000 | -26,184,000 | -63,316,000 | 506,301,000 | 93,924,000 | 252,177,000 |
| Dec 2025 | 120,989,000 | 84,268,000 | -14,235,000 | -17,666,000 | 523,710,000 | 104,997,000 | 215,528,000 |
| Sep 2025 | 116,743,000 | 84,527,000 | -3,251,000 | -7,635,000 | 493,902,000 | 95,968,000 | 201,644,000 |
| Jun 2025 | 102,692,000 | 70,902,000 | 8,960,000 | 10,809,000 | 463,863,000 | 74,120,000 | 186,730,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-9,311,000
Investing CF
$-69,364,000
Financing CF
$72,897,000
CapEx
$-19,341,000
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-2.30
As of
2026-05-10
Balance + Analyst (yfinance extras)
Retained Earnings
$-1,436,811,000
Inventory
$12,241,000
Receivables
$76,929,000
ST Investments
$76,761,000
EBIT TTM
$-67,808,000
Pretax Income TTM
$-77,474,000
Interest Exp TTM
$2,174,000
Analysts
9
Yahoo Snapshot (yfinance, live)
Total Revenue
$442,678,016
EBITDA
$-7,850,000
Free Cash Flow
$3,643,375
Enterprise Value
$1,402,047,616
Total Cash
$170,684,992
Total Debt
$168,192,000
Shares Out
29,688,027
Trailing EPS
$-2.66
Book Value
$10.54
ROE
-30.4%
ROA
-4.4%
Div Yield
—
Annual Trend (SEC EDGAR, last 5y)
Revenues vs Net Income (last 5y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 427,539,000 | -13,077,000 | -21,021,000 | 523,710,000 | 215,528,000 | — | 33,279,000 |
| Dec 2024 | 305,450,000 | -23,213,000 | -52,286,000 | 419,380,000 | 174,133,000 | — | -28,496,000 |
| Dec 2023 | 202,566,000 | -170,194,000 | -175,767,000 | 418,756,000 | 190,739,000 | — | -180,147,000 |
| Dec 2022 | 234,694,000 | -457,507,000 | -548,980,000 | 490,942,000 | 237,237,000 | — | -319,155,000 |
| Dec 2021 | — | — | — | — | — | — | — |
TTM Snapshot
Revenues TTM
$256,589,000
NetIncome TTM
$-95,448,000
OpCashFlow TTM
$0
Assets (Latest)
$419,380,000
Forward EPS
$1.23
Max Pain — expiry 2026-06-18 (volume-derived — Yahoo OI feed degraded)
max pain strike: $75.00 · spot: $49.44 · call volume: 674 · put volume: 767
Expected Move to 2026-06-18:
±$8.20
(16.59%) —
implied range
$41.24 –
$57.64
· ATM straddle on $50.00 strike
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| AGL | agilon health, inc. | $1.42B | $85.27 | — |
| AHCO | AdaptHealth Corp. | $1.41B | $10.36 | — |
| HCSG | HEALTHCARE SERVICES GROUP INC | $1.39B | $20.32 | — |
| AVAH | Aveanna Healthcare Holdings, Inc. | $1.59B | $7.28 | — |
| ARDT | Ardent Health, Inc. | $1.33B | $9.29 | — |
News headlines (Yahoo Finance, 1h cache)
GeneDx to Participate in the Goldman Sachs 47th Annual Global Healthcare Conference
2026-05-26 20:05 · Yahoo
This Healthcare Investor Added $43 Million to a Genomics Leader Growing Volume 34%
2026-05-23 20:37 · Yahoo
Ashland, GeneDX Holdings, and 3 More Stocks See Action From Activist Investors
2026-05-22 22:23 · Yahoo
Is GeneDx Stock a Buys After a Company Director Purchased Over 350,000 Shares?
2026-05-21 14:43 · Yahoo
Prenetics Starts Partnership with Jay Shetty as IM8 Global Ambassador & Shareholder
2026-05-20 20:51 · Yahoo
A Look At GeneDx Holdings (WGS) Valuation After Earnings Miss Guidance Cut And Securities Investigation
2026-05-16 15:12 · Yahoo
GeneDx (WGS) Fell Despite Continued Execution Improvement
2026-05-14 13:13 · Yahoo
Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought
2026-05-06 14:32 · Yahoo
The 'Alarming' Results That Caused GeneDx Stock To Plummet 49%
2026-05-05 20:30 · Yahoo
Why GeneDX Stock Is Plummeting Today
2026-05-05 15:23 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.